Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

The Center for Medicare and Medicaid Innovation may introduce a five-year pilot model to expand access to weight loss drugs, ...

Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid Services, discussed the impending changes to the ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

Dave Ramsey explains Medicare and Medicaid, highlighting differences and eligibility. Trump launches health tracking system ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

Trump abruptly fired Bureau of Labor Statistics Commissioner Erika McEntarfer on Friday after the release of the report, ...

Medicare Advantage, the privately run insurance on which roughly 500,000 older Louisiana residents rely for health care, is ...